Development Level

Tbio 3 | 10,625
Tchem 2 | 1,890

Disease

Cancer 4 | 2,346
Obesity 4 | 616
diabetes mellitus 4 | 1,663
Arthritis 3 | 248
Asthma 3 | 349
Autistic Disorder 3 | 320
Hyperglycemia 3 | 120
Hypertension 3 | 287
Metabolic syndrome X 3 | 155
Schizophrenia 3 | 501
breast carcinoma 3 | 1,614
ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
Alcohol dependence 2 | 107
Allergic hypersensitivity disease 2 | 123
Alzheimer's disease 2 | 644
Amenorrhea 2 | 60
Anorexia nervosa 2 | 59
Anovulation 2 | 20
Anxiety disorder 2 | 22
Cerebrovascular disease 2 | 231
Cocaine-Related Disorders 2 | 88
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Epilepsy 2 | 346
Fatty Liver 2 | 48
Heart disease 2 | 279
Heroin dependence 2 | 30
Hyperandrogenism 2 | 32
Hyperinsulinism 2 | 63
Hypertensive disease 2 | 193
Hyperthyroidism 2 | 50
Hypogonadism 2 | 70
Hypothyroidism 2 | 89
Infertility 2 | 163
Inflammatory bowel disease 2 | 142
Kidney disease 2 | 396
Klinefelter's syndrome 2 | 59
Liver Cirrhosis, Experimental 2 | 108
Liver disease 2 | 219
Major Depressive Disorder 2 | 106
Melanoma 2 | 261
Migraine 2 | 79
Neuropathy 2 | 210
Osteoporosis 2 | 257
Pain agnosia 2 | 99
Polycystic Ovary Syndrome 2 | 332
Proteinuria 2 | 63
Seizures 2 | 95
Weight Gain 2 | 87
Withdrawal disorder 2 | 19
adult high grade glioma 2 | 2,148
ACTH Syndrome, Ectopic 1 | 1
Acanthosis nigricans 1 | 14
Acne 1 | 20
Addison's disease 1 | 29
Adrenal Cortex Diseases 1 | 1
Adrenal cortical adenoma 1 | 10
Amnesia 1 | 17
Carney complex 1 | 23
Cerebral Hemorrhage 1 | 27
Chronic fatigue syndrome 1 | 29
Congenital adrenal insufficiency 1 | 7
Craniopharyngioma 1 | 13
Cystitis 1 | 16
Diabetes insipidus 1 | 14
Disorder of eye 1 | 7
Edema 1 | 38
Empty sella syndrome 1 | 6
Epilepsies, Myoclonic 1 | 5
Facial paralysis 1 | 15
Gastric ulcer 1 | 34
Glomerulonephritis 1 | 36
Gynecomastia 1 | 13
Hemorrhage 1 | 18
Hirsutism 1 | 2
Hyperprolactinemia 1 | 22
Hypertrophic Cardiomyopathy 1 | 56
Hypopituitarism 1 | 36
Hypotension 1 | 53
Insulin Resistance 1 | 48
Lipodystrophy 1 | 32
Liver Failure, Acute 1 | 22
Mood disorder 1 | 10
Multiple Endocrine Neoplasia Type 1 1 | 30
Nelson syndrome 1 | 6
Neurogenic Inflammation 1 | 12
Neurohypophyseal diabetes insipidus 1 | 13
Obesity, Morbid 1 | 6
Obstructive sleep apnea 1 | 28
Phaeochromocytoma 1 | 20
Primary pigmented nodular adrenocortical disease 1 | 12
Progeria 1 | 22
Pseudohermaphroditism 1 | 16
Rheumatic fever 1 | 16
Rosacea 1 | 18
Sleep Wake Disorders 1 | 5
Spinocerebellar ataxia type 5 1 | 6
Substance abuse 1 | 55
Synovitis 1 | 38
Thyroiditis 1 | 25

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 4 | 11,971
Enzyme 1 | 4,146

Grant Application

1F32DK082164-01 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-opiomelanocortin POMC Tbio Non-IDG -4.54944 36028.8 1100
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Tyrosine-protein phosphatase non-receptor type 1 PTPN1 Tchem Enzyme -3.01474 1197.1 449
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796
Splicing factor 1 SF1 Tbio Non-IDG -1.62635 45.1 258